We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Lab-on-a-Chip Nanotechnology Tracks Multiple Markers

By LabMedica International staff writers
Posted on 03 Jul 2017
Print article
Image: An artist’s rendition of microparticles flowing through a channel and passing through electric fields, where they are detected electronically and barcode-scanned (Photo courtesy of Ella Marushchenko and Alexander Tokarev, Ella Maru Studios).
Image: An artist’s rendition of microparticles flowing through a channel and passing through electric fields, where they are detected electronically and barcode-scanned (Photo courtesy of Ella Marushchenko and Alexander Tokarev, Ella Maru Studios).
Research engineers have invented a technology for nanoelectronic barcoding of microparticles that could be used in wearable or hand-held devices to analyze body fluids, such as sweat or blood, for various biomarkers or pollutants simultaneously.

The team, led by Mehdi Javanmard, assistant professor at Rutgers University-New Brunswick (New Brunswick, NJ), invented the biosensor technology to better monitor health and exposure to pathogenic microorganisms as well as to pollutants.

“This is really important in the context of personalized medicine or personalized health monitoring,” said Prof. Javanmard, “Our technology enables true labs on chips. We’re talking about platforms the size of a USB flash drive or something that can be integrated [into a fitness watch].”

In recent decades, research on biomarkers has revealed the complex nature of the molecular mechanisms behind human disease. That has heightened the importance of testing bodily fluids for numerous biomarkers simultaneously, the authors said.
“One biomarker is often insufficient to pinpoint a specific disease because of the heterogeneous nature of various types of diseases,” said Prof. Javanmard, “To get an accurate diagnosis and accurate management of various health conditions, you need to be able to analyze multiple biomarkers at the same time.”

Bulky optical instruments are the state-of-the-art technology for detecting and measuring biomarkers, but are too large to add to a portable device. Electronic detection of microparticles allows for ultra-compact instruments needed for wearable devices. The researchers’ technique for barcoding particles to identify them is, for the first time, fully electronic, allowing biosensors to be shrunk to the size of a wearable band or a microchip, the authors said.

The technology was greater than 95% accurate in identifying tested biomarkers, and fine-tuning is underway to make it 100% accurate, said Prof. Javanmard. The team is also working on portable detection of microrganisms, including pathogenic bacteria and viruses. “Imagine a small tool that could analyze a swab sample of what’s on the doorknob of a bathroom or front door and detect influenza or a wide array of other virus particles,” he said, “Imagine ordering a salad at a restaurant and testing it for E. coli or Salmonella bacteria.” This form of the tool could be commercially available within about two years, while health monitoring and diagnostic tools could be available within about five years, he said.

The study, by Xie P et al, was published April 28, 2017, in the journal Lab on a Chip.

Related Links:
Rutgers University-New Brunswick

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.